Tg(CAG-GLVP)#Cath
Transgene Detail
|
|
| Symbol: |
Tg(CAG-GLVP)#Cath |
| Name: |
transgene insertion, Charles A Thornton |
| MGI ID: |
MGI:5314751 |
| Synonyms: |
CAG-GLVP |
| Transgene: |
Tg(CAG-GLVP)#Cath Location: unknown
|
| Alliance: |
Tg(CAG-GLVP)#Cath page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: This transgene consists of the GLVPc914 cDNA (the GLVP transactivator) under the control of the CMV early enhancer/chicken beta actin (CAG) promoter. The GLVP portion consists of a mutated human progesterone receptor ligand binding domain fused to the yeast GAL4 DNA binding domain and the HSV VP16 transcriptional activation domain. Three lines were made, however the pound symbol (#) is used when line is not specified and/or lines are pooled.
(J:178541)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:178541 Mankodi A, et al., Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy. Neurobiol Dis. 2012 Jan;45(1):539-46 |
| All: |
1 reference(s) |
|
Analysis Tools
